15min chapter

In Good Company with Nicolai Tangen cover image

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation

In Good Company with Nicolai Tangen

CHAPTER

Navigating Drug Development Challenges

This chapter explores the intricate process of drug discovery, emphasizing the hurdles pharmaceutical companies face in target identification and medication effectiveness. It discusses the role of artificial intelligence in enhancing efficiencies and the contrasting drug approval timelines between the US and Europe. Additionally, the chapter highlights China's rapid improvements in drug regulation and the evolving dynamics of its pharmaceutical market.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode